Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Oct 03, 2023 9:30am
91 Views
Post# 35666509

A question I have. Was this Mr. Pidducks 'near term plan to

A question I have. Was this Mr. Pidducks 'near term plan togenerate cash'?  My thoughts is that it is not because the Tilray settlement was not a 100% actual cash settlement.  I guess we will have to wait if a bigger bang is still coming our way which based on what is in the works near term, FDA drug monograph, ANVISA approval, I am leaning to something bigger yet coming our direction.   

I wonder, what advanced preparations need to be made when you have visibility to new product launches.   A good place to start, your purchase order size, projected release volumes, the bill of materials followed through by establishing appropriate inventories including bottles, labels, packaging boxes, etc, etc.  
<< Previous
Bullboard Posts
Next >>